Workflow
ARYA Sciences Acquisition IV(ARYD)
icon
Search documents
ARYA Sciences Acquisition IV(ARYD) - 2021 Q1 - Quarterly Report
2021-05-12 16:00
Financial Performance - The company had a net loss of approximately $210,000 for the three months ended March 31, 2021, consisting of $225,000 in general and administrative expenses and $15,000 in gains on marketable securities, dividends, and interest held in the Trust Account[96]. - As of March 31, 2021, the company had approximately $810,000 in its operating bank account and working capital of approximately $1.3 million[97]. - The company has no operating history and no revenues, making it challenging to evaluate its ability to achieve business objectives[85]. Initial Public Offering (IPO) - The company raised gross proceeds of $149.5 million from its Initial Public Offering by selling 14,950,000 Class A ordinary shares at an offering price of $10.00 per share[87]. - The company incurred offering costs of approximately $8.8 million, including approximately $5.2 million in deferred underwriting commissions[87]. - Upon closing the Initial Public Offering, $149.5 million was placed in a Trust Account, invested only in U.S. government securities or money market funds[89]. - The company intends to use the proceeds from the Initial Public Offering and Private Placement for consummating a Business Combination[90]. - If a Business Combination is not completed within 24 months from the Initial Public Offering, the company will redeem Public Shares at a per-share price equal to the amount in the Trust Account[91]. - The underwriters received an underwriting discount of $0.20 per Public Share, totaling approximately $3.0 million, and deferred underwriting commissions of approximately $5.2 million[105]. Regulatory and Reporting Considerations - The company qualifies as an "emerging growth company" under the JOBS Act, allowing it to delay the adoption of new or revised accounting standards[110]. - The company is evaluating the benefits of relying on reduced reporting requirements provided by the JOBS Act, which may exempt it from certain disclosures for five years post-IPO[112]. - As a smaller reporting company, the company is not required to provide certain market risk disclosures[113]. Off-Balance Sheet Arrangements - As of March 31, 2021, the company had no off-balance sheet arrangements[109].